Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma

In the era of precision medicine, the tailoring of cancer treatment is increasingly important as we transition from organ‐based diagnosis towards a more comprehensive and patient‐centric molecular diagnosis. This is particularly the case for high‐grade serous adenocarcinomas of the ovary and periton...

Descripción completa

Detalles Bibliográficos
Autores principales: Anugraham, Merrina, Jacob, Francis, Everest‐Dass, Arun V., Schoetzau, Andreas, Nixdorf, Sheri, Hacker, Neville F., Fink, Daniel, Heinzelmann‐Schwarz, Viola, Packer, Nicolle H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663998/
https://www.ncbi.nlm.nih.gov/pubmed/28853212
http://dx.doi.org/10.1002/1878-0261.12134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663998/
https://www.ncbi.nlm.nih.gov/pubmed/28853212
http://dx.doi.org/10.1002/1878-0261.12134

Ejemplares similares